Oncolytics Biotech (ONCY) Current Leases (2019 - 2026)
Oncolytics Biotech (ONCY) posted quarterly Current Leases of $193000.0 for Q4 2025, down 2.67% year-over-year from $198290.2 in Q4 2024, and down 2.67% quarter-over-quarter from $198290.2 in Q4 2024.
Oncolytics Biotech (ONCY) Current Leases (2019 - 2026) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Current Leases for 7 consecutive years, with $193000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Leases fell 2.67% year-over-year to $193000.0; the TTM figure through Dec 2025 stood at $193000.0 (down 2.67% YoY), while the FY2025 annual figure was $193000.0, down 3.5% from the prior year.
- Current Leases eased to $193000.0 in Q4 2025 per ONCY's latest filing, from $198290.2 in the prior quarter.
- Across five years, Current Leases topped out at $233240.8 in Q4 2021 and bottomed at $97693.2 in Q4 2023.
- Historically, Current Leases has averaged $176270.4 across 5 years, with a median of $193000.0 in 2025.
- Annual changes were most pronounced in 2023 — Current Leases sank 38.61% — and 2024, when it jumped 102.97%.
- Oncolytics Biotech's Current Leases stood at $233240.8 in 2021, then sank by 31.78% to $159127.8 in 2022, then slumped by 38.61% to $97693.2 in 2023, then surged by 102.97% to $198290.2 in 2024, then declined by 2.67% to $193000.0 in 2025.
- Business Quant data shows ONCY's Current Leases at $193000.0 in Q4 2025, $198290.2 in Q4 2024, and $97693.2 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Oncolytics Biotech | 96.23 Mn | 96.23 Mn | - | 138,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 138,000.00 |
| Dec 31, 2025 | 193,000.00 |
| Dec 31, 2024 | 198,290.21 |
| Dec 31, 2023 | 97,693.23 |
| Dec 31, 2022 | 159,127.84 |
| Dec 31, 2021 | 233,240.81 |
| Dec 31, 2020 | 190,908.40 |
| Dec 31, 2019 | 257,432.79 |